BFBIO · Ratios · TradingHolo

Markets › Pakistan › KAR › BFBIO

BF Biosciences Ltd

KAR:BFBIOHealth TechnologyPSX:ALLSHRPSX:KMIALLSHR

Rs 125.61−0.36%LiveIn session · ≈ AED 1.67 · Market cap $40.91M · Next earnings Wed 2 Dec

🔔 Alert▶ Test a strategy

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	Trend	YoY
Gross margin	43.4%	28.8%	24.0%	40.9%	38.3%		−2.6 pts
Operating margin	34.8%	16.3%	13.9%	19.3%	12.6%		−6.7 pts
Net margin	34.6%	20.2%	8.2%	10.5%	7.7%		−2.9 pts
EBITDA margin	36.1%	18.1%	15.7%	20.3%	15.9%		−4.4 pts
Return on equity	41.5%	16.8%	7.6%	16.3%	9.6%		−6.7 pts
Return on assets	20.2%	6.9%	2.6%	6.6%	5.3%		−1.3 pts
Return on capital employed	24.0%	6.6%	5.9%	16.0%	10.8%		−5.2 pts
Debt / equity	0.6×	1.0×	1.3×	0.9×	0.4×		−60.5%
Debt / assets	29.6%	39.2%	45.8%	37.9%	20.4%		−17.5 pts
Interest coverage	24.2×	3.8×	1.6×	4.7×	5.9×		+25.5%
Current ratio	4.2×	3.2×	1.1×	1.2×	2.4×		+101.2%
Quick ratio	3.4×	2.6×	0.5×	0.5×	1.2×		+129.2%
Cash ratio	0.2×	0.3×	0.2×	0.3×	0.2×		−11.2%
Asset turnover	0.6×	0.3×	0.3×	0.6×	0.7×		+10.4%
Inventory turnover	2.7×	2.6×	1.6×	2.4×	2.0×		−17.4%
Receivables turnover	8.6×	6.6×	12.4×	13.6×	24.2×		+77.7%
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%		—

Margins, returns, leverage and liquidityUpdated 30 Jun 2025 ·

ⓘ